Unrevealed Depression Involves Dysfunctional Coping Strategies in Crohn's Disease Patients in Clinical Remission

Gastroenterology Research and Practice
Caterina ViganòGiovanni Maconi

Abstract

Background and Aims. This study investigated the proportion of CD patients in clinical remission with clinical depression, and coping strategies in those with severe depressive disorders. Materials and Methods. One hundred consecutive CD patients in clinical remission were screened for anxiety and depression by using Hospital Anxiety and Depression Scale and patients with depressive symptoms were further investigated by means of Cognitive Behavioural Assessment 2.0 and Beck Depression Inventory (BDI). Afterwards the coping strategies were assessed through the Brief-COPE questionnaire. Results. Twenty-one patients had anxious symptoms and 16 had depressive symptoms with or without anxiety. Seven of these patients (43.8%) showed significant depressive symptoms. Compared to patients without psychiatric disorders, these patients showed significant lower score in "positive reframing" (p: 0.017) and in "planning" (p: 0.046) and higher score in "use of instrumental social support" (p < 0.001), in "denial" scale (p: 0.001), and in "use of emotional social support" (p: 0.003). Conclusions. Depressed CD patients in clinical remission may have dysfunctional coping strategies, meaning that they may not be able to implement functional strat...Continue Reading

References

Apr 1, 1984·Journal of Personality and Social Psychology·A G Billings, R H Moos
Sep 15, 2000·Rheumatology·T CovicM Hough
Feb 6, 2004·General Hospital Psychiatry·Catherine Crane, Maryanne Martin
Jan 1, 1997·International Journal of Behavioral Medicine·C S Carver
Feb 17, 2006·Gut·R CaprilliUNKNOWN European Crohn's and Colitis Organisation
Sep 18, 2008·The American Journal of Gastroenterology·John R WalkerCharles N Bernstein
Jan 24, 2009·Inflammatory Bowel Diseases·Lesley A GraffCharles N Bernstein
Mar 10, 2010·Behaviour Research and Therapy·Renee J ThompsonIan H Gotlib
Sep 18, 2010·Journal of Psychosomatic Research·Cathy BrennanAllan House
Dec 3, 2010·Journal of Crohn's & Colitis·Gert Van AsscheUNKNOWN European Crohn's and Colitis Organisation (ECCO)
May 4, 2011·The American Journal of Gastroenterology·Edward V LoftusParvez M Mulani
Feb 2, 2012·Inflammatory Bowel Diseases·Stéphane NahonJean-Pierre Gendre
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Christopher EcclestonEmily Law
Oct 23, 2012·Journal of Crohn's & Colitis·Marta Iglesias-ReyEnrique Domínguez-Muñoz
Mar 1, 2013·Inflammatory Bowel Diseases·Neal S LeLeikoBarbara Bancroft
May 15, 2013·Inflammatory Bowel Diseases·Clarence K ZhangDeborah D Proctor
Oct 1, 2013·Journal of Crohn's & Colitis·Antonina Mikocka-Walus, Jane M Andrews
Nov 7, 2013·Inflammatory Bowel Diseases·Marta Iglesias-ReyJ E Dominguez-Munoz
Dec 1, 1995·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·P M NicassioK Dwyer
Nov 16, 2013·Journal of Crohn's & Colitis·Daniela RoglerUNKNOWN Swiss IBD Cohort Study Group
Mar 13, 2014·Scandinavian Journal of Gastroenterology·Valérie PittetUNKNOWN Swiss IBD Cohort Study Group
Jun 24, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Eva SzigethyDavid R DeMaso
Jul 6, 2014·International Journal of Colorectal Disease·Giovanni MaconiGabriella Ba
Dec 3, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Gengxiang WuJing Wen

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioural therapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.